Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Ruxolitinib in the management of chronic GVHD.
Giden AO, Erkurt MA, Hindilerden IY, Hidayet E, Berber I, Tiryaki TO, Zorlu T, Namdaroglu S, Sarici A, Aksoy E, Yildizhan E, Aydin MS, Korkmaz S, Dal MS, Ulas T, Altuntas F. Giden AO, et al. Among authors: tiryaki to. Transfus Apher Sci. 2024 Dec 17;64(1):104053. doi: 10.1016/j.transci.2024.104053. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39708419
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL.
Akpinar S, Dogu MH, Celik S, Ekinci O, Hindilerden IY, Dal MS, Davulcu EA, Tekinalp A, Hindilerden F, Ozcan BG, Hacibekiroglu T, Erkurt MA, Bagci M, Namdaroglu S, Korkmaz G, Bilgir O, Cagliyan GA, Ozturk HBA, Serin I, Tiryaki TO, Ozatli D, Korkmaz S, Ulas T, Eser B, Turgut B, Altuntas F. Akpinar S, et al. Among authors: tiryaki to. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):169-173. doi: 10.1016/j.clml.2021.09.010. Epub 2021 Sep 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34629286
Comprehensive mastocytosis data analysis from a single center.
Tiryaki TO, Özkan SG, Erdem S, Aday AD, Hindilerden İY, Gelincik A, Baykal C, Yegen G, Doğan İÖ, Büyükbabani N, Nalçacı M, Yavuz AS. Tiryaki TO, et al. BMC Cancer. 2023 Jan 24;23(1):82. doi: 10.1186/s12885-022-10498-3. BMC Cancer. 2023. PMID: 36694141 Free PMC article.
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?
Ulas T, Namdaroglu S, Hindilerden IY, Erkurt MA, Erer K, Yigenoglu TN, Tiryaki TO, Hidayet E, Korkmaz S, Ulu BU, Yilmaz S, Kaya E, Pepeler MS, Basturk A, Dal MS, Altuntas F. Ulas T, et al. Among authors: tiryaki to. Transfus Apher Sci. 2024 Dec 17;64(1):104058. doi: 10.1016/j.transci.2024.104058. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39700842 Review.
Are mesenchymal stem cells still effective in acute GvHD management?
Ulu BU, Hindilerden IY, Yigenoglu TN, Tiryaki TO, Erkurt MA, Korkmaz G, Namdaroglu S, Aksoy E, Korkmaz S, Seyhan M, Yilmaz S, Besisik SK, Dal MS, Ulas T, Altuntas F. Ulu BU, et al. Among authors: tiryaki to. Transfus Apher Sci. 2024 Dec 16;64(1):104051. doi: 10.1016/j.transci.2024.104051. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39721135
Immunosuppressive Treatment in C3 Glomerulopathy: Is it Really Effective?
Caliskan Y, Torun ES, Tiryaki TO, Oruc A, Ozluk Y, Akgul SU, Temurhan S, Oztop N, Kilicaslan I, Sever MS. Caliskan Y, et al. Among authors: tiryaki to. Am J Nephrol. 2017;46(2):96-107. doi: 10.1159/000479012. Epub 2017 Jul 13. Am J Nephrol. 2017. PMID: 28700996
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience.
Özbalak M, Güzel Mastanzade M, Özlük Ö, Tiryaki TO, Erdem S, Özbalak EP, Elverdi T, Yönal Hindilerden İ, Altay AY, Yeğen G, Eşkazan AE, Ar MC, Yenerel MN, Soysal T, Nalçacı M, Ferhanoğlu B, Kalayoğlu Beşışık S. Özbalak M, et al. Among authors: tiryaki to. Turk J Haematol. 2022 Dec 1;39(4):254-261. doi: 10.4274/tjh.galenos.2022.2022.0142. Epub 2022 Jun 3. Turk J Haematol. 2022. PMID: 35657203 Free PMC article.
20 results